Skip to content

MEDIFRY

Active
Private limited companyfounded 20214 yrs activeSimarstrasse 29, 4700 Eupen, BelgiumKBO/BCE: BE 0774.898.455

The computed 12-month bankruptcy probability of MEDIFRY is 2.6% (moderate). The 2025 annual accounts show equity of €44k and a net result of €74k. The figures fluctuate too strongly year-on-year for a reliable trend projection. The company has been active since 2021 and the Belgian State Gazette contains no insolvency or warning signals.

Checked score

Score 2025
64 / 100
Healthy
The score weighs solvency, liquidity and profitability. Bankruptcy probability contributes 35%. Every signal that weighs is under Signals.
Axes · tick = 2024
Profitability100=
Solvency53▼-47
Growth68▼-10
Track record94
Bankruptcy probability, 12 months
2.6% Moderate
0%0.5%1.5%4%10%≥ 25%
Credit up to €2.5k at 30 days acceptable
Liquidity tight (current ratio 1.33 against 5.22 in 2024; short-term debt: 72.3% and cash: 74.4% of total assets), and 72.3% of the assets are financed with debt.
Credit advice for your own amount and term

Signals

Seven signals. The signal on the left, the evidence on the right.
lowers risk+raises riskneutral
raises risk · Limited track record
This company has not been active as long as an established one and statistically fails somewhat more often.
KBO · incorporation date
Age against the risk zone
elevated failure risk from 2 to 8 years 4 years 0 10 y
raises risk · No NACE activity registered
No NACE activity is registered in the KBO, which is more common among companies that later fail.
KBO · activities
lowers risk · Annual accounts: healthy financial profile
The latest annual accounts show a healthy profile in solvency, result and liquidity.
NBB · annual accounts 2025
Solvency, return and age of the figures
Solvency
27.7%
Return on assets
46.8%
Age of the figures
9 mo
raises risk · Higher-failure-rate region
In this region companies fail more often than in the rest of the country.
KBO · registered office
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 24-07-2026, 7 days ahead of the deadline.
NBB · 4 filings
Deviation from the deadline
2025
7 d early
2024
21 d late
2023
21 d late
2022
67 d late
← before the deadline after the deadline →
neutral · The next deadline is still running
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today.
Companies Code · seven months
Position in the running window
23-09-2026 today31-12-2026 close31-07-2027 deadline
neutral · No strike-offs in the KBO publications
We found no ex-officio strike-off or cessation. Our series starts in 2021 and has gaps, so this is not a confirmation that there is nothing.
KBO publications · our coverage

Financials · fiscal year 2025, micro schema

Equity
€44k▼ 77.9%
2024 · €199k
2022: €44k 2023: €97k 2024: €199k
2022 → 2025
Total assets
€159k▼ 34.8%
2024 · €243k
2022: €119k 2023: €184k 2024: €243k
2022 → 2025
Net result
€74k▼ 27.6%
2024 · €103k
2022: €43k 2023: €53k 2024: €103k
2022 → 2025
Working capital
€38k▼ 79.8%
2024 · €186k
2022: €21k 2023: €76k 2024: €186k
2022 → 2025
Multi-year overview
Every figure with its change against the year before
▲ rise ▼ fall
Line2022202320242025Trend
Equity€44k-€97k▲ 119%€199k▲ 106%€44k▼ 77.9%
Operating result€64k-€71k▲ 10.9%€138k▲ 93.5%€97k▼ 30.0%
Net result€43k-€53k▲ 22.2%€103k▲ 95.1%€74k▼ 27.6%
Turnover and EBIT margin not published: the micro schema does not require them.
Result per fiscal year
Operating resultNet result
€0€50k€100k€150kOperating result 2022: €64k€64kNet result 2022: €43k€43kOperating result 2023: €71k€71kNet result 2023: €53k€53kOperating result 2024: €138k€138kNet result 2024: €103k€103kOperating result 2025: €97k€97kNet result 2025: €74k€74k2022202320242025
The operating result falls in 2025; 2025 is 30% below 2024.
Balance-sheet composition
2025 in colour, 2024 as the grey bar beneath
Assets €159k
Fixed assets €6k▼ 51.1%
Current assets €152k▼ 33.9%
Equity and liabilities €159k
Equity €44k▼ 77.9%
Debt €115k▲ 160%
The debt ratio rises from 18.1% to 72.3%. Equity is lower and debt is higher.
Key figures and ratios
2025 value · change against 2024
EBITDA
€104k
2024 · €146k
Cash flow
€81k
2024 · €110k
Solvency
27.7%
2024 · 81.9%
Current ratio
1.33
2024 · 5.22
Quick ratio
1.33
2024 · 5.22
Debt / equity
2.60
2024 · 0.22
ROE
168.8%
2024 · 51.5%
ROA
46.8%
2024 · 42.2%
Interest coverage
849.84
2024 · 1086.71
Debt
€115k
2024 · €44k
Debt ≤ 1 year
€115k
2024 · €44k
Income taxes
€26k
2024 · €36k
Green means a favourable move, even when the figure itself falls: as with debt or debt / equity.
Filed annual accounts
As filed with the NBB · 2025 against 2024
Balance sheet Code20242025
Assets
Total assets20/58€243k€159k
Fixed assets21/28€13k€6k
Tangible fixed assets22/27€8k€1k
Furniture and vehicles24€8k€1k
Financial fixed assets28€5k€5k=
Current assets29/58€230k€152k
Amounts receivable within one year40/41€110k€34k
Trade receivables40€110k€33k
Other amounts receivable41-€311
Current investments50/53€100k-
Cash at bank and in hand54/58€20k€118k
Deferred charges and accrued income490/1€591€588
Equity and liabilities
Total equity and liabilities10/49€243k€159k
Equity10/15€199k€44k
Contributions10/11€1k€1k=
Reserves13€43k€43k=
Distributable reserves133€43k€43k=
Profit (loss) carried forward14€155k-
Amounts payable17/49€44k€115k
Amounts payable within one year42/48€44k€115k
Trade debts44€2k€3k
Suppliers440/4€2k€3k
Taxes, remuneration and social security45€36k€36k
Taxes450/3€36k€36k
Other amounts payable47/48€6k€75k
Income statement Code20242025
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€7k€7k
Other operating charges640/8€284€403
Gross operating margin9900€146k€104k
Operating profit (loss)9901€138k€97k
Financial income75/76B-€4k
Recurring financial income75-€4k
Financial charges65/66B€134€122
Recurring financial charges65€134€122
Profit (loss) for the period before taxes9903€138k€100k
Income taxes67/77€36k€26k
Profit (loss) for the period9904€103k€74k
Profit (loss) for the period to be appropriated9905€103k€74k
Appropriation of the result
Profit (loss) to be appropriated9906€155k€230k
Profit (loss) brought forward from the previous period14P€53k€155k
Profit to be distributed694/7-€230k
Return on contributions (dividend)694-€230k

The notes to these accounts (7 items: statements of assets and debts, cost breakdowns, rights and commitments) are not shown here.

Download as CSV

Timeline · acts, filings and financial milestones

Next filing, fiscal year 2026, expected by 31-07-2027
2026
24-07
NBB filing Annual accounts filed
fiscal year 2025 · micro schema
2025
21-08
NBB filing Annual accounts filed
fiscal year 2024 · micro schema · 21 days late
2024
31-12
Financial Highest result since 2022net €103k ▲95.1%
Operating result €138k, net result €103k, both a record.
31-12
Financial Liquidity triplescurrent ratio 5.22
Current ratio from 1.87 to 5.22; short-term debt falls from €88k to €44k.
31-12
Financial Equity above €150kEq €199k ▲106%
3 profitable years in a row build equity to €199k.
21-08
NBB filing Annual accounts filed
fiscal year 2023 · micro schema · 21 days late
2023
06-10
NBB filing Annual accounts filed
fiscal year 2022 · micro schema · 67 days late
Financial milestoneNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.

Directors · office · real estate

Directors
2 acts for this company are in the Belgian State Gazette, of which we have read 0. We have therefore not extracted its directors from those acts yet.
Location & real-estate footprint
Registered office, Eupen · 1 establishment unit since 2021
establishment The establishment unit on the map
Cannot be placed on the map

This address could not be matched to a point in the Belgian address register (BOSA BEST). The address below comes straight from the Crossroads Bank.

Simarstrasse 294700 Eupen
Ground area
1,040 m²
Building footprint
133 m²
Volume, LiDAR
867 m³
Parcel 63084A0187/00H004, Wallonia · tallest building 8.6 m, ±2 floors. Linked by address, not a title deed.
1 establishment unit
MEDIFRY
Rue de la Croix 14, 4840 WelkenraedtGeneral medical practice
since 20212.322.799.414
1 parcel
Wallonia 1 (100%)
Parcel (capakey) Region Area Buildings Height / fl.
63084A0187/00H004 Wallonia 1,040 m² 1 · 133 m² 8.6 m · 2 fl.
Linked by address, not proof of ownership
Methodology
via establishment units: 1
1 of 1 parcel with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.

Company data · Crossroads Bank

Identification
Legal formPrivate limited company
Founded01-10-2021
Fiscal year end31-12
Sources
Crossroads Bank for EnterprisesNational Bank · 4 filingsAddress and cadastre registers

Data from official sources, last processed on 21-09-2026. Scores and ratios are computed by Checked and are not a credit decision.